Breaking News, Promotions & Moves

Odyssey Therapeutics Appoints Jolie Siegel EVP and General Counsel

Siegel will lead Odyssey’s legal, compliance, governance, and risk management functions.

Author Image

By: Patrick Lavery

Content Marketing Editor

Odyssey Therapeutics has named Jolie Siegel Executive Vice President and General Counsel. In this role, Siegel is expected to lead the company’s legal, compliance, governance, and risk management functions. She will also serve as a strategic partner to the Odyssey executive team and Board of Directors. Odyssey, a clinical-stage biopharmaceutical company, recently appointed another Executive Vice President. Dennis Dean, PhD, was named EVP and Head of Non-Clinical Development in November 2025. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters